ATLANTA, April 10,
2023 /PRNewswire/ -- Artivion, Inc. (NYSE:
AORT), a leading cardiac and vascular surgery company focused
on aortic disease, today announced that it will participate
virtually at the upcoming 22nd Annual Needham Virtual
Healthcare Conference. The Company's virtual fireside chat is
scheduled to begin at 8:45 a.m. ET on
April 18, 2023.
A live webcast of the virtual fireside chat will be accessible
through Artivion's website, www.artivion.com, on the Investors
page. An archived copy of the webcast will be available for
90 days on the same website.
About Artivion, Inc.
Headquartered in suburban
Atlanta, Georgia, Artivion, Inc.
is a medical device company focused on developing simple, elegant
solutions that address cardiac and vascular surgeons' most
difficult challenges in treating patients with aortic diseases.
Artivion's four major groups of products include: aortic stents and
stent grafts, surgical sealants, On-X mechanical heart valves, and
implantable cardiac and vascular human tissues. Artivion markets
and sells products in more than 100 countries worldwide. For
additional information about Artivion, visit our website,
www.artivion.com.
|
Contacts:
|
|
|
|
|
|
|
Artivion
|
|
Gilmartin Group LLC
|
|
D. Ashley
Lee
|
|
Brian Johnston / Lynn
Lewis
|
|
Executive Vice
President and
|
|
Phone:
332-895-3222
|
|
Chief Financial
Officer
|
|
investors@artivion.com
|
|
Phone:
770-419-3355
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-the-22nd-annual-needham-virtual-healthcare-conference-301793567.html
SOURCE Artivion, Inc.
